Charles Schwab Investment Management Inc Chroma Dex Corp. Transaction History
Charles Schwab Investment Management Inc
- $429 Billion
- Q1 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Chroma Dex Corp. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 24,667 shares of CDXC stock, worth $67,340. This represents 0.0% of its overall portfolio holdings.
Number of Shares
24,667
Previous 24,667
-0.0%
Holding current value
$67,340
Previous $35,000
142.86%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding CDXC
# of Institutions
71Shares Held
13.1MCall Options Held
97.1KPut Options Held
17.6K-
Vanguard Group Inc Valley Forge, PA3.05MShares$8.32 Million0.0% of portfolio
-
Tieton Capital Management, LLC Yakima, WA3.02MShares$8.25 Million5.51% of portfolio
-
Iconiq Capital, LLC San Francisco, CA1.3MShares$3.54 Million0.08% of portfolio
-
Black Rock Inc. New York, NY903KShares$2.47 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny584KShares$1.6 Million0.0% of portfolio
About ChromaDex Corp.
- Ticker CDXC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,350,896
- Market Cap $187M
- Description
- ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...